Boryung Pharmaceutical Co., Ltd.

https://www.boryung.co.kr

Established in 1963, Boryung Pharmaceutical has been one of Korea`s leading pharmaceutical companies with sales revenue of KRW 400 billion, 1,155 employees and 550 sales representatives as of 2015. The company is fully integrated from R&D through manufacturing, marketing and sales with an established presence in Korea. The company has focused on the development and commercialization of new pharmaceutical products. Its main therapeutic categories are oncology, cardiovascular, anti-infective, respiratory and others. Especially Boryung is the strongest company in anti-cancer market in Korea. *

	Start	1963-01-01 established
	Industry	pharmaceutical
	Industry 2	cancer drug

	City	n. a.
		Address record changed: 2020-12-02

Basic data	Employees	F: 1,001 to 5,000 (2015-12-31)
	Currency	KRW
	Annual sales	400,000,000,000 (sales revenue (2015) 2015-12-31)

		* Document for »About Section«:

		Record changed: 2023-07-10

Picture Berlin Partner Voices Robinson Data for Precision Medicine 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]